| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.1 | $0-$5k | 0.00 |
Summary
A vulnerability marked as problematic has been reported in Kaspersky Endpoint Security and Industrial CyberSecurity for Linux Nodes. The impacted element is an unknown function. This manipulation causes cross site scripting. This vulnerability appears as CVE-2025-64984. The attack may be initiated remotely. There is no available exploit. It is suggested to upgrade the affected component.
Details
A vulnerability was found in Kaspersky Endpoint Security and Industrial CyberSecurity for Linux Nodes (the affected version is unknown). It has been declared as problematic. Affected by this vulnerability is an unknown code. The manipulation with an unknown input leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. As an impact it is known to affect integrity. The summary by CVE is:
Kaspersky has fixed a security issue in Kaspersky Endpoint Security for Linux (any version with anti-virus databases prior to 18.11.2025), Kaspersky Industrial CyberSecurity for Linux Nodes (any version with anti-virus databases prior to 18.11.2025), and Kaspersky Endpoint Security for Mac (12.0.0.325, 12.1.0.553, and 12.2.0.694 with anti-virus databases prior to 18.11.2025) that could have allowed a reflected XSS attack to be carried out by an attacker using phishing techniques.
It is possible to read the advisory at support.kaspersky.com. This vulnerability is known as CVE-2025-64984 since 11/12/2025. The exploitation appears to be easy. The attack can be launched remotely. The exploitation doesn't need any form of authentication. It demands that the victim is doing some kind of user interaction. The technical details are unknown and an exploit is not publicly available. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.
Upgrading eliminates this vulnerability.
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Vendor
Name
License
Website
- Vendor: https://www.kaspersky.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 5.2VulDB Meta Temp Score: 5.1
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 6.1
CNA Vector (Kaspersky): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Timeline
11/12/2025 CVE reserved11/20/2025 Advisory disclosed
11/20/2025 VulDB entry created
11/20/2025 VulDB entry last update
Sources
Vendor: kaspersky.comAdvisory: support.kaspersky.com
Status: Confirmed
CVE: CVE-2025-64984 (🔒)
GCVE (CVE): GCVE-0-2025-64984
GCVE (VulDB): GCVE-100-333043
Entry
Created: 11/20/2025 08:56Changes: 11/20/2025 08:56 (73)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.

No comments yet. Languages: en.
Please log in to comment.